267 related articles for article (PubMed ID: 14752059)
1. The fenfluramine metabolite (+)-norfenfluramine is vasoactive.
Ni W; Li MW; Thakali K; Fink GD; Watts SW
J Pharmacol Exp Ther; 2004 May; 309(2):845-52. PubMed ID: 14752059
[TBL] [Abstract][Full Text] [Related]
2. The 5-hydroxytryptamine2A receptor is involved in (+)-norfenfluramine-induced arterial contraction and blood pressure increase in deoxycorticosterone acetate-salt hypertension.
Ni W; Fink GD; Watts SW
J Pharmacol Exp Ther; 2007 May; 321(2):485-91. PubMed ID: 17289838
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the contractile 5-hydroxytryptamine receptor in the renal artery of the normotensive rat.
Watts SW; Thompson JM
J Pharmacol Exp Ther; 2004 Apr; 309(1):165-72. PubMed ID: 14724222
[TBL] [Abstract][Full Text] [Related]
4. Possible role of valvular serotonin 5-HT(2B) receptors in the cardiopathy associated with fenfluramine.
Fitzgerald LW; Burn TC; Brown BS; Patterson JP; Corjay MH; Valentine PA; Sun JH; Link JR; Abbaszade I; Hollis JM; Largent BL; Hartig PR; Hollis GF; Meunier PC; Robichaud AJ; Robertson DW
Mol Pharmacol; 2000 Jan; 57(1):75-81. PubMed ID: 10617681
[TBL] [Abstract][Full Text] [Related]
5. (+)-Norfenfluramine-induced arterial contraction is not dependent on endogenous 5-hydroxytryptamine or 5-hydroxytryptamine transporter.
Ni W; Wilhelm CS; Bader M; Murphy DL; Lookingland K; Watts SW
J Pharmacol Exp Ther; 2005 Sep; 314(3):953-60. PubMed ID: 15901794
[TBL] [Abstract][Full Text] [Related]
6. 5-Hydroxytryptamine(2B) receptor function is enhanced in the N(omega)-nitro-L-arginine hypertensive rat.
Russell A; Banes A; Berlin H; Fink GD; Watts SW
J Pharmacol Exp Ther; 2002 Oct; 303(1):179-87. PubMed ID: 12235249
[TBL] [Abstract][Full Text] [Related]
7. The 5-hydroxytryptamine2B receptor and 5-HT receptor signal transduction in mesenteric arteries from deoxycorticosterone acetate-salt hypertensive rats.
Watts SW; Baez M; Webb RC
J Pharmacol Exp Ther; 1996 May; 277(2):1103-13. PubMed ID: 8627522
[TBL] [Abstract][Full Text] [Related]
8. Naturally occurring clavines: antagonism/partial agonism at 5-HT2A receptors and antagonism at alpha 1-adrenoceptors in blood vessels.
Pertz H
Planta Med; 1996 Oct; 62(5):387-92. PubMed ID: 8923801
[TBL] [Abstract][Full Text] [Related]
9. Molecular determinants for the interaction of the valvulopathic anorexigen norfenfluramine with the 5-HT2B receptor.
Setola V; Dukat M; Glennon RA; Roth BL
Mol Pharmacol; 2005 Jul; 68(1):20-33. PubMed ID: 15831837
[TBL] [Abstract][Full Text] [Related]
10. Evidence that hypophagia induced by d-fenfluramine and d-norfenfluramine in the rat is mediated by 5-HT2C receptors.
Vickers SP; Dourish CT; Kennett GA
Neuropharmacology; 2001 Aug; 41(2):200-9. PubMed ID: 11489456
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the serotonin receptor mediating contraction in the mouse thoracic aorta and signal pathway coupling.
McKune CM; Watts SW
J Pharmacol Exp Ther; 2001 Apr; 297(1):88-95. PubMed ID: 11259531
[TBL] [Abstract][Full Text] [Related]
12. Hypotensive and antiaggregative effects of eugenosedin-B with serotonin and alpha/beta-adrenoceptor antagonistic activities in rats and human platelets.
Shen KP; Chu LW; Hsieh SL; An LM; Chen IJ; Wu BN
J Cardiovasc Pharmacol; 2008 Feb; 51(2):154-61. PubMed ID: 18287883
[TBL] [Abstract][Full Text] [Related]
13. An investigation of the effects of intravenous injection of the 5-hydroxytryptamine 2 receptor antagonists ketanserin and LY 53857 on blood pressure in anesthetized spontaneously hypertensive rats.
Docherty JR
J Pharmacol Exp Ther; 1989 Feb; 248(2):736-40. PubMed ID: 2537414
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the contractile 5-hydroxytryptamine receptor in the autoperfused kidney of L-NAME hypertensive rats.
Morán A; de Urbina AV; Martín ML; Rodríguez-Barbero A; Román LS
Eur J Pharmacol; 2009 Oct; 620(1-3):90-6. PubMed ID: 19699736
[TBL] [Abstract][Full Text] [Related]
15. (+)-Fenfluramine and its major metabolite, (+)-norfenfluramine, are potent substrates for norepinephrine transporters.
Rothman RB; Clark RD; Partilla JS; Baumann MH
J Pharmacol Exp Ther; 2003 Jun; 305(3):1191-9. PubMed ID: 12649307
[TBL] [Abstract][Full Text] [Related]
16. Roles of 5-hydroxytryptamine (5-HT) receptor subtypes in the inhibitory effects of 5-HT on C-fiber responses of spinal wide dynamic range neurons in rats.
Liu FY; Xing GG; Qu XX; Xu IS; Han JS; Wan Y
J Pharmacol Exp Ther; 2007 Jun; 321(3):1046-53. PubMed ID: 17329553
[TBL] [Abstract][Full Text] [Related]
17. Characterization of 5-HT receptor subtypes mediating contraction in human umbilical vein. 1. Evidence of involvement of 5-HT2A receptors using functional and radioligand binding assays.
Rogines-Velo MP; Pelorosso FG; Zold CL; Nowak W; Pesce GO; Sardi SP; Brodsky PT; Rothlin RP
Naunyn Schmiedebergs Arch Pharmacol; 2002 Dec; 366(6):587-95. PubMed ID: 12444501
[TBL] [Abstract][Full Text] [Related]
18. Serotonin 5-ht2c receptor agonists: potential for the treatment of obesity.
Miller KJ
Mol Interv; 2005 Oct; 5(5):282-91. PubMed ID: 16249524
[TBL] [Abstract][Full Text] [Related]
19. Effects of antagonists of 5-hydroxytryptamine on blood pressure in the anesthetised spontaneously hypertensive rat.
Docherty JR; Warnock P
J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S59-61. PubMed ID: 2446073
[TBL] [Abstract][Full Text] [Related]
20. LY53857, a selective and potent serotonergic (5-HT2) receptor antagonist, does not lower blood pressure in the spontaneously hypertensive rat.
Cohen ML; Fuller RW; Kurz KD
J Pharmacol Exp Ther; 1983 Nov; 227(2):327-32. PubMed ID: 6313898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
